We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toHealth-Canada-Town-Hall

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.


What's New in Health Canada: Updates and New Endeavors

    Session Chair(s)
      Agnes V. Klein, MD

      Agnes V. Klein, MD

      • Director, Evaluation of Radiopharmaceuticals and Biotherapeutic Products
      • Health Canada, Canada
    This froum will discuss the new approaches Health Canada proposes to take in making drugs necessary to the healthcare system available earlier and in a more streamlined fashion. This is also an opportunity to strengthen older endeavors.
    Learning Objective : • Participants will have a thorough knowledge of work currently underway regarding Regulatory Review of Drugs and Devices (R2D2) • Participants will understand their potential involvement and areas for collaboration on R2D2 projects • Participants from other regulatory agencies will see the benefits of possibly proceeding with some of the R2D2 projects in their jurisdiction
    Speaker(s)
      Michèle  Chadwick, MBA

      Improving Access to Necessary Therapeutic Products in Canada

      Michèle Chadwick, MBA

      • Lead, Regulatory Review of Drugs and Devices, HPFB
      • Health Canada, Canada
      Agnes V. Klein, MD

      Updates on Biosimilars

      Agnes V. Klein, MD

      • Director, Evaluation of Radiopharmaceuticals and Biotherapeutic Products
      • Health Canada, Canada
      Marilena  Bassi, MA

      Regulator Perspective on the Opioid Crisis

      Marilena Bassi, MA

      • Director of the Bureau of Policy
      • Health Canada, Canada